Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment
Clinical trial NCT01022762 · COMPLETED
Trial details
- NCT number
- NCT01022762
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-11-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.